For personal use only

Market Announcement
6 July 2020

Recce Pharmaceuticals Ltd (ASX: RCE) – Trading Halt
Description
The securities of Recce Pharmaceuticals Ltd (‘RCE’) will be placed in trading halt at the request of RCE, pending
it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the
earlier of the commencement of normal trading on Wednesday, 8 July 2020 or when the announcement is
released to the market.

Issued by
Madeleine Green
Senior Adviser, Listings Compliance (Perth)

6 July 2020
ASX Limited

Market Announcement 1/1
ASX Customer Service Centre 131 279 | asx.com.au

For personal use only

6 July 2020
Sean Maloney
Adviser, Listings Compliance (Perth)
Level 40 Central Park
152 - 158 St George’s Terrace
PERTH WA 6000
By email:

tradinghaltsperth@asx.com.au

Dear Sean

Recce Pharmaceuticals Ltd (ASX:RCE) – Trading halt request
Pursuant to ASX Listing Rule 17.1, Recce Pharmaceuticals Ltd ACN 124 849 065 (Company)
requests a trading halt of the Company’s securities pending the release of an announcement
relating to a Material Research Agreement.
The Company requests that the trading halt be effective immediately and remain in place until the
earlier of the commencement of normal trading on Wednesday 8 July 2020 or the release of an
announcement by the Company in relation to a Material Research Agreement.
The Company is not aware of any reason why the trading halt should not be granted.
For any questions, please contact the undersigned on +61 2 8072 1400.
Yours faithfully

Alistair McKeough
Company Secretary

